A major step forward in the fight against Alzheimer’s Disease! Leading scientists, clinicians, and industry partners gathered in Olomouc, Czechia, on March 24-25, 2025, for the 4th meeting of the 2D-BioPAD project. Our mission? To develop a fast, reliable, affordable, and digital system for early Alzheimer’s detection.
The two-day meeting, hosted by our coordinator, CATRIN, at the RCPTM building, was packed with updates. The team reviewed the latest research on aptamer candidates—tiny molecules that help detect Alzheimer’s biomarkers like Aβ40, Aβ42, pTau-217, NfL, and GFAP. Our partners also made progress in using magnetic nanoparticles (MNPs) to capture these biomarkers efficiently.
Technical experts led interactive workshops on developing cutting-edge biosensors, setting clear goals to have the first working prototypes ready by September 2025. Members of the Scientific and Industrial Advisory Board (SIAB) shared valuable insights on regulatory approvals and clinical testing.
The second day focused on spreading the word about 2D-BioPAD. Plans were also made for collaboration at Graphene Week 2025. Another key discussion was how to bring this game-changing device to market, ensuring it meets real-world needs.
To wrap up, the team joined the SUSNANO workshop on nanobiosensors, connecting with other experts and exploring future partnerships.
The next big milestone? Testing real blood samples with the first integrated prototype this September!
